AP NEWS

2 Day Conference: Next-Gen Regenerative Medicine & Tissue Engineering - ResearchAndMarkets.com

August 20, 2018

DUBLIN--(BUSINESS WIRE)--Aug 20, 2018--The “Next-Gen Regenerative Medicine & Tissue Engineering Conference” conference has been added to ResearchAndMarkets.com’s offering.

Ethical and regulatory parameters lay a special emphasis on animal modeling to carry forward the researches over tissue engineering and organ transplantation. This is one of the major challenge being faced for the clinical applications of regenerative medicine.

The translational research promises to improvise a structural shift in healthcare by focusing on the underlying causes of disease by repairing, replacing, or regenerating damaged cells in the body. The conference aims on these similar lines to assess risks and benefits of regenerative medicine through the application of cellular therapies, stem cells and biocompatible materials.

The event provider has put together a platform for the leading experts of industry to discuss strategies, technologies and innovations in tissue engineering & biomaterials, cellular therapies and diagnosis of regenerative medicines at the Next-Gen Regenerative Medicine & Tissue Engineering Conference.

Key Highlights

Cell based tissue engineering Tissue-specific biomarkers Tissue scaffolding Cell surface profiling Processing of iPSC cells iPSC derived mesenchymal cells T-cell identification and regulation Regulatory and ethical issues of regenerative medicines Genetic models for neurodegenerative disorders Organ transplantation and regeneration

Speakers

Advisory Committee:

Francisco Vidal Fayos Director, Aastrom Biosciences

Dr. Tiffany Rau Senior Consultant, Bioprocessing Technology Consultants

Alain Vertes Managing Director, NxR Biotechnlogies GMBH

Expert Speakers:

Alain Vertes Managing Director, NxR Biotechnlogies GMBH, Switzerland

Wilfred T.V. Germeraad Chief Scientific Officer, CiMaas BV, Netherlands

Philippe Henon President & Chief Scientific Officer, CellProthera, France

Roland Klar Head of Regenerative Medicine, Ludwig Maximilian University of Munich, Germany

Yang (Ted) D. Teng Ph.D., M.D., Departments of Physical Medicine & Rehabilitation (PM&R) & Neurosurgery, Harvard Medical School, Boston, MA, USA

Suwan N. Jayasinghe Professor, Bioengineering, University College London, UK

James Adjaye Chair of Stem Cell Research & Regenerative Medicine, Director, Institute for Stem Cell Research & Regenerative Medicine, Germany

Alexander Seflian Director & Professor of Nanotechnology & Regenerative Medicine, The London BioScience Innovation Center,UK

Antonio Apicella Researcher, University of Campania, Italy

Roland Hetzer Cardiac Surgeon, Germany

Oliver Betz Director, Regenerative Medicine, Ludwig-Maximilians -University, of Munich, Germany

Tiffany Rau Senior Consultant, Bioprocessing Technology Consultants, USA

David Gilham Vice President, Research & Development, Celyad, Belgium

For more information about this conference visit https://www.researchandmarkets.com/research/d3jjs6/2_day_conference?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180820005253/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals ,Biomaterials

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/20/2018 07:35 AM/DISC: 08/20/2018 07:35 AM

http://www.businesswire.com/news/home/20180820005253/en

AP RADIO
Update hourly